Supernus Pharmaceuticals | Zahlungsmittel Und Äquivalente



Cash And Equivalent Veränderung Datum
Abbott USD 6.95B 419M 2025-06
ANI Pharmaceuticals USD 217.8M 67.99M 2025-06
Aurora Cannabis CAD 140.16M 31.45M 2025-06
Bristol-Myers Squibb USD 12.6B 1.72B 2025-06
Canopy Growth CAD 126.2M 109.89M 2025-06
Corcept Therapeutics USD 102.74M 12.93M 2025-06
Eisai JPY 285.38B 19.82B 2025-06
Eli Lilly USD 3.38B 282.6M 2025-06
Novo Nordisk A/S 18.44B 5.78B 2025-06
Pacira USD 300.48M 16.87M 2025-06
Perrigo USD 454.2M 44.3M 2025-06
Pfizer USD 1.64B 208M 2025-06
Supernus Pharmaceuticals USD 144.71M 28.86M 2025-06
United Therapeutics USD 1.59B 306.8M 2025-06
Xeris Pharmaceuticals USD 59.28M 12.34M 2025-06


Supernus Pharmaceuticals Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.